Scientific Advisory Council

Dirk Jaeger, MD

National Center for Tumor Diseases Heidelberg

Heidelberg, Germany

Dr. Dirk Jaeger is the managing director and the head of the Department of Medical Oncology at the National Center for Tumor Diseases of the University Clinic of Heidelberg, where he focuses on translating innovative immunotherapies into early clinical trials. Dr. Jaeger is a member of CRI’s Clinical Leadership Committee.

This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.